Recursion Pharmaceuticals

Biotech company industrializing drug discovery using machine learning and automation

Salt Lake City, United States Founded 2013 501-1000 employees SaaS

About Recursion Pharmaceuticals

Recursion Pharmaceuticals is a clinical-stage biotechnology company applying artificial intelligence and automation to drug discovery and development. Its approach combines biological experiments, high-dimensional data, computational analysis, and pharmaceutical research to investigate disease mechanisms and identify potential treatments. The company describes this integrated technology and biology platform as Recursion OS. Recursion’s research process uses automated laboratories to generate large datasets from cellular experiments, including observations of how cells respond to chemical compounds and genetic changes. Machine learning and computational tools help researchers connect these biological patterns with disease hypotheses and potential therapeutic opportunities. The company advances selected programs through preclinical research and clinical development, and collaborates with pharmaceutical and technology partners. Recursion focuses on areas of significant medical need, including oncology and rare diseases, and maintains a pipeline of potential medicines at different stages of development. The company is relevant to searches for AI drug discovery, biotechnology, computational biology, automated laboratories, precision medicine research, and pharmaceutical R&D. Its model aims to combine experimental biology with data science to make drug discovery more systematic and scalable.